StockWatch
·

Venmax Drugs And Pharmaceuticals Ltd Q1 FY27 Results

VENMAXQ1 FY27 Results
Filing
Result:Good· Market: Flat#Base effect#Margin expansion
MetricValue ( Cr)Q4 FY26Q1 FY26
Revenue2.4837.1%104.9%
Total Income2.4838.6%104.9%
Expenditure2.3639.9%101.5%
PBT0.1211.6%211.5%
Net Profit0.128.8%211.8%
OPM4.74%4.40pp1.56pp
NPM4.70%2.04pp1.61pp
EPS0.1052.4%42.9%
View full financials

Revenue and PAT growth look eye-catching but are off a very small base (~₹1.2cr revenue, ₹0.04cr PAT a year ago), with margin expansion (OPM 3.2%→4.7%) still leaving thin absolute profitability, so it's healthy but not a true standout.

Informational and educational content only. Not investment advice.